Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diazepam for acute dyspnea control in the emergency department
IRCT20141209020258N122Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of diazepam in Dyspnoea (SOB) (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Respiratory distress, Level of consciousness and 1 more. Started Mar 2018; status: completed.
02
Drugs
diazepam
03
Conditions
Dyspnoea (SOB)
Beyond the preview
Go deeper on IRCT20141209020258N122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N122.